Daily SPAC Update – July 26, 2024

by David Pogemiller | Jul 26, 2024

Churchill Capital VII Adjourns Deal Vote to August. IRAA Increases PIPE. ARYD + Adagio Medical Deal Vote.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

MERGER VOTES
ARYD + ADAGIO MEDICAL, INC.

OTHER SPAC NEWS
CVII – CHURCHILL CAPITAL CORP VII * Vote Adjourn
EMLD – FTAC EMERALD ACQUISITION CORP * Merger Agreement
IRAA – IRIS ACQUISITION CORP * Increased PIPE
AEI CapForce II Investment Corp * Registration Withdrawn
NFYS – ENPHYS ACQUISITION CORP * Suspended Trading

SPAC IPO
Jul 24: DTSQ – Dt Cloud Star Acquisition Corp $60M IPO – trades July 25

SPAC DEAL TERMINATIONS (Last 10 Days)
2024-07-23: PWUP + Visiox Pharmaceuticals

YESTERDAY’S TOP SPAC GAINERS
7.41% ~ $ 12.90 | PTWO – Pono Capital Two, Inc. (Announced)
2.13% ~ $ 11.98 | TRON – Corner Growth Acquisition Corp. 2 (Pre-Deal)
1.60% ~ $ 11.46 | MAQC – Maquia Capital Acquisition Corporation (Announced)
1.59% ~ $ 7.05 | CETU – Cetus Capital Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-3.78% ~ $ 10.68 | ARYD – ARYA Sciences Acquisition Corp IV (Announced)
-3.52% ~ $ 15.64 | ADRT – Ault Disruptive Technologies Corp (Announced)
-1.84% ~ $ 12.30 | CLOE – Clover Leaf Capital Corp. (Announced)
-1.53% ~ $ 11.62 | PPYA – Papaya Growth Opportunity Corp. I (Pre-Deal)
-1.30% ~ $ 11.29 | TGAA – Target Global Acquisition I Corp. (Pre-Deal)

Recent Analysis

Daily SPAC Update – March 14, 2025

Finnovate Delays Deal Vote Again. Bannix Acquisition (BNIX) Extends. Bukit Jalil (BUJA) and Sk Growth (SKGR) Votes Set. Columbus Acquisition (COLA) Separate Trading.

Daily SPAC Update – March 12, 2025

Perception Capital IV / Blue Gold Deal Approved. Inflection Point (IPXX) Forward Purchase Agreement. K&F Growth Separate Trading Starts Tomorrow.

Will a Proxy Fight with Anson Save Match Group?

Match (MTCH) has three powerful activists pushing for change. Will a stagnant, entrenched board see the light or waste shareholder dollars fighting change?

Whetstone Capital Advisors Launches Proxy Fight at OptimizeRX

Whetstone Capital will likely get its two board seats and strategic changes, but longer-term shareholders likely won’t recoup their losses.

Daily SPAC Update – March 11, 2025

USA Rare Earth Deal with Inflection Point Acquisition II Approved. Liminatus Pharma + Iris Acquisition Approved. Aquaron Delisting. SK Growth and Oak Woods Get Vote Dates.

Subscribe to Boardroom Alpha Newsletters

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.